Laurus Labs Ltd.

NSE: LAURUSLABS | BSE: 540222 | ISIN: INE947Q01028 | Industry: Pharmaceuticals
| Mid-range Performer
992.6000 31.20 (3.25%)
NSE Mar 24, 2026 15:31 PM
Volume: 1.5M
 

logo
Laurus Labs Ltd.
20 May 2025
992.60
3.25%
AUM Capital
Laurus Labs Ltd (Laurus) was incorporated in the year 2005 as an Anti-Retroviral (ARV) Active Pharmaceutical Ingredient (API) company. (ARV drugs are medications used to treat HIV infection and prevent its progression). Later, it diversified its operations by entering into Formulations and Contract Development Manufacturing Operations (CDMO) services to become an integrated pharma company. Currently, Laurus's...
Motilal Oswal released a Buy report for Laurus Labs Ltd. with a price target of 1280.0 on 19 Mar, 2026.
More from Laurus Labs Ltd.
Recommended